Cargando…
Validation of a blood protein signature for non-small cell lung cancer
BACKGROUND: CT screening for lung cancer is effective in reducing mortality, but there are areas of concern, including a positive predictive value of 4% and development of interval cancers. A blood test that could manage these limitations would be useful, but development of such tests has been impai...
Autores principales: | Mehan, Michael R, Williams, Stephen A, Siegfried, Jill M, Bigbee, William L, Weissfeld, Joel L, Wilson, David O, Pass, Harvey I, Rom, William N, Muley, Thomas, Meister, Michael, Franklin, Wilbur, Miller, York E, Brody, Edward N, Ostroff, Rachel M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123246/ https://www.ncbi.nlm.nih.gov/pubmed/25114662 http://dx.doi.org/10.1186/1559-0275-11-32 |
Ejemplares similares
-
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
por: Ostroff, Rachel M., et al.
Publicado: (2010) -
Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
por: Ostroff, Rachel M., et al.
Publicado: (2012) -
Protein Signature of Lung Cancer Tissues
por: Mehan, Michael R., et al.
Publicado: (2012) -
Automated Lobe-Based Airway Labeling
por: Gu, Suicheng, et al.
Publicado: (2012) -
Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules
por: Birse, Charles E., et al.
Publicado: (2017)